Hiroki Ide
Impact in
Papers in
- Surgery 45
- Bladder and Urothelial Cancer Treatments 43
- Urinary and Genital Oncology Studies 15
-
- Prostate Cancer Treatment and Research 11
- Co-authors
- Hiroshi Miyamoto (34 shared papers)Satoshi Inoue (28 shared papers)Takashi Kawahara (18 shared papers)Eiji Kashiwagi (19 shared papers)Eiji Kikuchi (31 shared papers)Mototsugu Oya (30 shared papers)Yichun Zheng (12 shared papers)Taichi Mizushima (22 shared papers)
- Journals
- Japanese Journal of Clinical Oncology (8 papers)The Journal of Urology (6 papers)Oncotarget (4 papers)Urologic Oncology Seminars and Original Investigations (4 papers)British Journal of Cancer (4 papers)
- Partner nations
- JapanUnited StatesChina
In The Last Decade
Hiroki Ide
84 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 94
- Surgery 858
- Urology 97
- Oncology 366
- Cancer Research 183
- Pulmonary and Respiratory Medicine 341
Countries citing papers authored by Hiroki Ide
This map shows the geographic impact of Hiroki Ide's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroki Ide with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroki Ide more than expected).
Fields of papers citing papers by Hiroki Ide
This network shows the impact of papers produced by Hiroki Ide. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroki Ide. The network helps show where Hiroki Ide may publish in the future.
Co-authors
The 25 scholars most cited alongside Hiroki Ide, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 87 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 87 | |
| 2 | 2015 | 76 | |
| 3 | 2012 | 64 | |
| 4 | 2015 | 58 | |
| 5 | 2014 | 56 | |
| 6 | 2016 | 56 | |
| 7 | 2017 | 55 | |
| 8 | 2014 | 53 | |
| 9 | 2012 | 49 | |
| 10 | 2016 | 43 | |
| 11 | 2015 | 41 | |
| 12 | 2018 | 41 | |
| 13 | 2017 | 41 | |
| 14 | 2016 | 40 | |
| 15 | 2013 | 39 | |
| 16 | 2013 | 37 | |
| 17 | 2017 | 37 | |
| 18 | 2008 | 32 | |
| 19 | 2013 | 32 | |
| 20 | Silodosin inhibits the growth of bladder cancer cells and enhances the cytotoxic activity of cisplatin via ELK1 inactivation. | 2015 | 32 |
About Hiroki Ide
Hiroki Ide is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Molecular Biology, Oncology and Cancer Research, having authored 87 papers that have together received 1.8k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (43 papers), Urinary and Genital Oncology Studies (15 papers), Prostate Cancer Treatment and Research (11 papers), Estrogen and related hormone effects (5 papers), Cancer, Lipids, and Metabolism (5 papers), Urinary Bladder and Prostate Research (4 papers), Inflammatory mediators and NSAID effects (4 papers) and Inflammatory Biomarkers in Disease Prognosis (4 papers). The work is most often cited by research in Surgery (858 citations), Urology (97 citations), Oncology (366 citations), Cancer Research (183 citations) and Pulmonary and Respiratory Medicine (341 citations). Hiroki Ide has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Hiroshi Miyamoto, Satoshi Inoue, Takashi Kawahara, Eiji Kashiwagi, Eiji Kikuchi, Mototsugu Oya, Yichun Zheng, Taichi Mizushima, George J. Netto and Akira Miyajima. Their work appears in journals such as Japanese Journal of Clinical Oncology, The Journal of Urology, Oncotarget, Urologic Oncology Seminars and Original Investigations and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.